Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor.

Anat Levit Kaplan, Ryan T Strachan, Joao M Braz, Veronica Craik, Samuel Slocum, Thomas Mangano, Vanessa Amabo, Henry O'Donnell, Parnian Lak, Allan I Basbaum, Bryan L Roth, Brian K Shoichet

Journal of medicinal chemistry 2022 Mar 10

filter terms:

The 5-HT5A receptor (5-HT5AR), for which no selective agonists and a few antagonists exist, remains the least understood serotonin receptor. A single commercial antagonist, SB-699551, has been widely used to investigate the 5-HT5AR function in neurological disorders, including pain, but this molecule has substantial liabilities as a chemical probe. Accordingly, we sought to develop an internally controlled probe set. Docking over 6 million molecules against a 5-HT5AR homology model identified 5 mid-μM ligands, one of which was optimized to UCSF678, a 42 nM arrestin-biased partial agonist at the 5-HT5AR with a more restricted off-target profile and decreased assay liabilities versus SB-699551. Site-directed mutagenesis supported the docked pose of UCSF678. Surprisingly, analogs of UCSF678 that lost the 5-HT5AR activity revealed that 5-HT5AR engagement is nonessential for alleviating pain, contrary to studies with less-selective ligands. UCSF678 and analogs constitute a selective probe set with which to study the function of the 5-HT5AR.

Citation

Anat Levit Kaplan, Ryan T Strachan, Joao M Braz, Veronica Craik, Samuel Slocum, Thomas Mangano, Vanessa Amabo, Henry O'Donnell, Parnian Lak, Allan I Basbaum, Bryan L Roth, Brian K Shoichet. Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor. Journal of medicinal chemistry. 2022 Mar 10;65(5):4201-4217